Cigna Group (CI) concluded trading on Wednesday at a closing price of $294.03, with 4.28 million shares of worth about $1.26 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.50% during that period and on December 11, 2024 the price saw a loss of about -5.57%. Currently the company’s common shares owned by public are about 279.50M shares, out of which, 272.90M shares are available for trading.
Stock saw a price change of -10.93% in past 5 days and over the past one month there was a price change of -14.29%. Year-to-date (YTD), CI shares are showing a performance of -1.81% which decreased to -2.63% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $288.88 but also hit the highest price of $370.83 during that period. The average intraday trading volume for Cigna Group shares is 1.60 million. The stock is currently trading -9.72% below its 20-day simple moving average (SMA20), while that difference is down -10.59% for SMA50 and it goes to -13.76% lower than SMA200.
Cigna Group (NYSE: CI) currently have 279.50M outstanding shares and institutions hold larger chunk of about 88.71% of that.
The stock has a current market capitalization of $81.79B and its 3Y-monthly beta is at 0.51. PE ratio of stock for trailing 12 months is 27.73, while it has posted earnings per share of $10.60 in the same period. Its PEG reads 2.31 while making debt-to-equity ratio of 0.78. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CI, volatility over the week remained 3.21% while standing at 2.25% over the month.
Stock’s fiscal year EPS is expected to rise by 13.60% while it is estimated to increase by 10.67% in next year. EPS is likely to grow at an annualized rate of 12.00% for next 5-years, compared to annual growth of 10.54% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on June 26, 2024 offering an Overweight rating for the stock and assigned a target price of $400 to it. Coverage by Robert W. Baird stated Cigna Group (CI) stock as an Outperform in their note to investors on May 30, 2024, suggesting a price target of $388 for the stock. On March 06, 2024, Barclays Initiated their recommendations, while on February 05, 2024, RBC Capital Mkts Upgrade their ratings for the stock with a price target of $354. Stock get an Overweight rating from Cantor Fitzgerald on February 05, 2024.
